Long-acting treatment for opioid addiction reduced risk of relapse
In a multicenter, randomized clinical trial, ex-prisoners who received six monthly injections of naltrexone—a long-acting medication that blocks opioid receptors in the brain—were significantly less likely to resume opioid ...
Mar 30, 2016
0
31